GLP1R and diabetes mellitus: Instead, in subjects with T2DM the insulin secretion did not increase when compared with GLP-1 infusion alone, but there was an increase when compared with GIP and placebo administration, emphasizing the reduced insulinotropic effect of GIP in patients with diabetes.